Shandong Weigao Orthopaedic Device Co. Ltd. A
Shandong Weigao Orthopaedic Device Co., Ltd. operates as a orthopedic implant medical device and pharmaceutical company. The company offers general consumables, such as clinical care consumables and supplies, infection protection supplies, infusion consumables, indwelling needle, anesthesia respiratory consumables, other operating room consumables, and other clinical consumables; endocrine consum… Read more
Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) - Net Assets
Latest net assets as of June 2025: CN¥4.05 Billion CNY
Based on the latest financial reports, Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) has net assets worth CN¥4.05 Billion CNY as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.04 Billion) and total liabilities (CN¥992.87 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥4.05 Billion |
| % of Total Assets | 80.31% |
| Annual Growth Rate | 16.09% |
| 5-Year Change | 60.84% |
| 10-Year Change | N/A |
| Growth Volatility | 35.93 |
Shandong Weigao Orthopaedic Device Co. Ltd. A - Net Assets Trend (2019–2024)
This chart illustrates how Shandong Weigao Orthopaedic Device Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Shandong Weigao Orthopaedic Device Co. Ltd. A (2019–2024)
The table below shows the annual net assets of Shandong Weigao Orthopaedic Device Co. Ltd. A from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.96 Billion | +2.30% |
| 2023-12-31 | CN¥3.87 Billion | -22.61% |
| 2022-12-31 | CN¥5.01 Billion | +10.32% |
| 2021-12-31 | CN¥4.54 Billion | +84.15% |
| 2020-12-31 | CN¥2.46 Billion | +31.16% |
| 2019-12-31 | CN¥1.88 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Shandong Weigao Orthopaedic Device Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 444.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥2.12 Billion | 53.51% |
| Other Components | CN¥1.84 Billion | 46.49% |
| Total Equity | CN¥3.95 Billion | 100.00% |
Shandong Weigao Orthopaedic Device Co. Ltd. A Competitors by Market Cap
The table below lists competitors of Shandong Weigao Orthopaedic Device Co. Ltd. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Capital Futures Corp
TW:6024
|
$171.88 Million |
|
Chunbo Co. Ltd
KQ:278280
|
$171.96 Million |
|
ADCNF
OTCGREY:ADCNF
|
$172.01 Million |
|
Zhejiang Oceanking Development Co Ltd
SHG:603213
|
$172.01 Million |
|
Idorsia Ltd
PINK:IDRSF
|
$171.80 Million |
|
ECHO INVESTMENT ZY 005
F:4I3
|
$171.78 Million |
|
Bohai Water Industry Co Ltd
SHE:000605
|
$171.74 Million |
|
29METALS Ltd
AU:29M
|
$171.73 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shandong Weigao Orthopaedic Device Co. Ltd. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,868,918,256 to 3,953,519,924, a change of 84,601,668 (2.2%).
- Net income of 223,751,739 contributed positively to equity growth.
- Dividend payments of 75,254,750 reduced retained earnings.
- Other factors decreased equity by 63,895,322.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥223.75 Million | +5.66% |
| Dividends Paid | CN¥75.25 Million | -1.9% |
| Other Changes | CN¥-63.90 Million | -1.62% |
| Total Change | CN¥- | 2.19% |
Book Value vs Market Value Analysis
This analysis compares Shandong Weigao Orthopaedic Device Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.18x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 6.02x to 3.18x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | CN¥5.22 | CN¥31.44 | x |
| 2020-12-31 | CN¥6.84 | CN¥31.44 | x |
| 2021-12-31 | CN¥11.33 | CN¥31.44 | x |
| 2022-12-31 | CN¥12.51 | CN¥31.44 | x |
| 2023-12-31 | CN¥9.67 | CN¥31.44 | x |
| 2024-12-31 | CN¥9.88 | CN¥31.44 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shandong Weigao Orthopaedic Device Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.66%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.40%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.25x
- Recent ROE (5.66%) is below the historical average (13.69%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 23.60% | 28.06% | 0.49x | 1.72x | CN¥254.50 Million |
| 2020 | 22.76% | 30.62% | 0.57x | 1.30x | CN¥313.02 Million |
| 2021 | 15.23% | 32.05% | 0.40x | 1.19x | CN¥237.16 Million |
| 2022 | 12.00% | 29.19% | 0.34x | 1.20x | CN¥100.11 Million |
| 2023 | 2.90% | 8.75% | 0.25x | 1.32x | CN¥-274.58 Million |
| 2024 | 5.66% | 15.40% | 0.29x | 1.25x | CN¥-171.60 Million |
Industry Comparison
This section compares Shandong Weigao Orthopaedic Device Co. Ltd. A's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,879,733,462
- Average return on equity (ROE) among peers: 24.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) | CN¥4.05 Billion | 23.60% | 0.25x | $171.85 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $792.82 Million | 25.77% | 0.17x | $318.98 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $482.51 Million | 20.84% | 0.32x | $2.79 Billion |
| Double Medical Technology Inc (002901) | $224.61 Million | 43.10% | 0.32x | $404.40 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $1.42 Million | 98.49% | 2.27x | $281.14 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $2.71 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $637.77 Million |
| Edan Instruments Inc (300206) | $1.26 Billion | 7.37% | 0.15x | $501.55 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $504.27 Million | 13.31% | 0.36x | $360.97 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $267.10 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $952.60 Million |